Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

IRF4 Expression in Germinal Center and Lymphoma B Cells Regulates Antigen-Dependent Immune Response

Patrizia Mondello, Prithviraj Mukherjee, Geoffrey Nelson, Surendra Dasari, Christine Hachfeld, Vaishali Bhardwaj, Xinyi Tang, Zhi-Zhang Yang, Zhiquan Wang, Megan Weivoda, Mark Shlomchik, Laura Pasqualucci, Karen Adelman, Stephen M Ansell

Blood (2023) 142 (Supplement 1): 4142.

https://doi.org/10.1182/blood-2023-174580

Published: 2023

Journal Articles

IRF4 Rewires Tumor Metabolism with Functional Implications on the Immune Microenvironment in Lymphoma

Patrizia Mondello, Vaishali Bhardwaj, Kerstin Wenzl, Joshua Olson, Christine Hachfeld, Prithviraj Mukherjee, Xinyi Tang, Joseph P. Novak, Zhi-Zhang Yang, Megan Weivoda, Nicholas Graham, Laura Pasqualucci, Mark Shlomchik, Anne J. Novak, Stephen M Ansell

Blood (2023) 142 (Supplement 1): 1643.

https://doi.org/10.1182/blood-2023-178120

Published: 2023

Journal Articles

A Novel High-Throughput Method for Identifying T-Cell Receptor: Minor Histocompatibility Antigen Interactions in Mouse Models of Graft-Vs-Host Disease

Kevin Quann, Kentin Codispot, Alexander M. Rowe, Wenzhong Wei, Daniel Wikenheiser, Emily McFerran, Mark Shlomchik, Warren Shlomchik

Blood (2023) 142 (Supplement 1): 4791.

https://doi.org/10.1182/blood-2023-190970

Published: 2023

Journal Articles

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD + AML or ALL or Poor/Very Poor Risk MDS

Sawa Ito, Christine Voigt, Constantinos Panousis, Tim Mayall, Mark Shlomchik, Jennifer Roy, Egidio Brocca Cofano, Stephanie Stras, David Apelian, Warren D Shlomchik

Blood (2022) 140 (Supplement 1): 7482–7483.

https://doi.org/10.1182/blood-2022-168949

Published: 2022

Journal Articles

The Irf4 Gene, a Susceptibility Locus for Chronic Lymphocytic Leukemia (CLL), Controls Establishment of Follicular and Marginal Zone B Cell Compartments in Mice

Giorgia Simonetti, Amanda Carette, Haowei Wang, MD, Mark Shlomchik, MD, PhD, Ulf Klein, Ph.D.

Blood (2011) 118 (21): 285.

https://doi.org/10.1182/blood.V118.21.285.285

Published: 2011

Journal Articles

Donor B-Cell Alloantibody Deposition and Germinal Center Formation Are Required for the Development of Murine Chronic Gvhd and Bronchiolitis Obliterans

Mathangi Srinivasan, PhD, Ryan Flynn, Andrew Price, Ann Ranger, PhD, Jeffrey L Browning, Patricia A Taylor, DVM, Jerome Ritz, MD, Joseph H. Antin, MD, William J Murphy, PhD, Leo Luznik, Mark Shlomchik, MD, PhD, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD

Blood (2011) 118 (21): 307.

https://doi.org/10.1182/blood.V118.21.307.307

Published: 2011

Journal Articles

A New TCR Transgenic Model of GVHD Reveals That, Independent of Repertoire, Effector Memory T Cells Are Severely Limited, and Central Memory T Cells Somewhat Limited, in Their Ability to Cause GVHD.

Kathryn N Wilkinson, Britt Anderson, PhD, Jennifer McNiff, MD, Anthony Jake Demetris, Warren D. Shlomchik, MD, Mark Shlomchik, MD, PhD

Blood (2009) 114 (22): 233.

https://doi.org/10.1182/blood.V114.22.233.233

Published: 2009

Journal Articles

Toll-Like Receptor and Autoimmunity.

Mark Shlomchik, MD, PhD, Kevin Nickerson, Rebecca Sweet, Sean Christensen, Robin Herlands

Blood (2009) 114 (22): SCI-24.

https://doi.org/10.1182/blood.V114.22.SCI-24.SCI-24

Published: 2009

Journal Articles

Recipient Langerhans Cells Are Neither Required Nor Sufficient for GVHD Induction in MHC-Matched Allogeneic BMT, but a Langerin+ Cell Is a Pivotal Regulator of Langerhans Cell Turnover Post Transplantation

Hongmei Li, MD, Daniel Kaplan, MD, PhD, Anthony Jake Demetris, MD, Jennifer McNiff, MD, Mark Shlomchik, MD, PhD, Warren D. Shlomchik, MD

Blood (2008) 112 (11): 3511.

https://doi.org/10.1182/blood.V112.11.3511.3511

Published: 2008

NARROW

IRF4 Expression in Germinal Center and Lymphoma B Cells Regulates Antigen-Dependent Immune Response

IRF4 Rewires Tumor Metabolism with Functional Implications on the Immune Microenvironment in Lymphoma

A Novel High-Throughput Method for Identifying T-Cell Receptor: Minor Histocompatibility Antigen Interactions in Mouse Models of Graft-Vs-Host Disease

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD + AML or ALL or Poor/Very Poor Risk MDS

The Irf4 Gene, a Susceptibility Locus for Chronic Lymphocytic Leukemia (CLL), Controls Establishment of Follicular and Marginal Zone B Cell Compartments in Mice

Donor B-Cell Alloantibody Deposition and Germinal Center Formation Are Required for the Development of Murine Chronic Gvhd and Bronchiolitis Obliterans

A New TCR Transgenic Model of GVHD Reveals That, Independent of Repertoire, Effector Memory T Cells Are Severely Limited, and Central Memory T Cells Somewhat Limited, in Their Ability to Cause GVHD.

Toll-Like Receptor and Autoimmunity.

Recipient Langerhans Cells Are Neither Required Nor Sufficient for GVHD Induction in MHC-Matched Allogeneic BMT, but a Langerin+ Cell Is a Pivotal Regulator of Langerhans Cell Turnover Post Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only